Literature DB >> 27025597

Tumor lysis-like syndrome in a child during treatment for visceral leishmaniasis.

Athanasios Tragiannidis1, Maria Papageorgiou2, Maria Stamou2, Emmanuel Hatzipantelis2, Theodotis Papageorgiou2, Andreas Giannopoulos2, Lamprini Damianidou2, Anna Pappa3, Stiliani Pappa3, Maria Hatzistilianou2.   

Abstract

A 2.5-year-old girl was admitted due to splenomegaly and pancytopenia. Laboratory analysis revealed pancytopenia and hypergammaglobulinemia, and due to the absence of fever and the relevant clinical and hematological presentation the child was initially suspected for acute lymphoblastic leukemia. Bone marrow aspiration displayed macrophages and extracellular space containing Leishmania amastigotes. Visceral leishmaniasis diagnosis due to Leishmania infantum was confirmed by the presence of high titers of Leishmania antibodies and by PCR. The patient was successfully treated with liposomal amphotericin B but during the third post-treatment day significant increases in the levels of serum uric acid, blood urea nitrogen, and phosphate were registered. The child was successfully treated with hydration and urine alkalization and resulted in full recovery of the metabolic abnormalities.
© The Author(s) 2016.

Entities:  

Keywords:  childhood; liposomal amphotericin B; lysis syndrome; visceral leishmaniasis

Mesh:

Substances:

Year:  2016        PMID: 27025597      PMCID: PMC5806763          DOI: 10.1177/0394632016640788

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  10 in total

1.  Kala-azar--progress against a neglected disease.

Authors:  Henry W Murray
Journal:  N Engl J Med       Date:  2002-11-28       Impact factor: 91.245

2.  Lysis syndrome during therapy of visceral leishmaniasis.

Authors:  E N Liberopoulos; A A Kei; M S Elisaf
Journal:  Infection       Date:  2011-10-18       Impact factor: 3.553

Review 3.  Tumor lysis syndrome: A clinical review.

Authors:  Aibek E Mirrakhimov; Prakruthi Voore; Maliha Khan; Alaa M Ali
Journal:  World J Crit Care Med       Date:  2015-05-04

Review 4.  Leishmaniasis in immunosuppressed individuals.

Authors:  J van Griensven; E Carrillo; R López-Vélez; L Lynen; J Moreno
Journal:  Clin Microbiol Infect       Date:  2014-02-20       Impact factor: 8.067

5.  Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece.

Authors:  Sarah P Georgiadou; Aggelos Stefos; Gregory Spanakos; Stergios Skrimpas; Konstantinos Makaritsis; Nikolaos V Sipsas; George N Dalekos
Journal:  Int J Infect Dis       Date:  2015-03-03       Impact factor: 3.623

Review 6.  Immune responses in kala-azar.

Authors:  Samiran Saha; Smriti Mondal; Antara Banerjee; Jayeeta Ghose; Sudipta Bhowmick; Nahid Ali
Journal:  Indian J Med Res       Date:  2006-03       Impact factor: 2.375

7.  A tumor lysis-like syndrome during therapy of visceral leishmaniasis.

Authors:  Evagelos Liberopoulos; George Alexandridis; Moses Elisaf
Journal:  Ann Clin Lab Sci       Date:  2002       Impact factor: 1.256

Review 8.  Leishmaniasis.

Authors:  B L Herwaldt
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

Review 9.  Visceral leishmaniasis: host-parasite interactions and clinical presentation in the immunocompetent and in the immunocompromised host.

Authors:  Laura Saporito; Giovanni M Giammanco; Simona De Grazia; Claudia Colomba
Journal:  Int J Infect Dis       Date:  2013-02-04       Impact factor: 3.623

10.  Leishmaniases in Greece.

Authors:  Pantelis Ntais; Dimitra Sifaki-Pistola; Vasiliki Christodoulou; Ippokratis Messaritakis; Francine Pratlong; George Poupalos; Maria Antoniou
Journal:  Am J Trop Med Hyg       Date:  2013-09-23       Impact factor: 2.345

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.